"insulin aspart" meaning in English

See insulin aspart in All languages combined, or Wiktionary

Noun

IPA: /ˌɪn.səl.ɪn ˈæ.spɑɹt/ [General-American]
Etymology: From insulin + aspart(ate). Etymology templates: {{af|en|insulin|aspartate|alt2=aspart(ate)}} insulin + aspart(ate) Head templates: {{en-noun|-}} insulin aspart (uncountable)
  1. (pharmacology) A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others. Tags: uncountable Categories (topical): Pharmaceutical drugs Hypernyms: insulin analogue Coordinate_terms (Insulin analogues as pharmaceutical drugs): insulin degludec, insulin detemir, insulin glargine, insulin glulisine, insulin lispro
    Sense id: en-insulin_aspart-en-noun-PnPtLXUy Categories (other): English entries with incorrect language header Topics: medicine, pharmacology, sciences

Download JSON data for insulin aspart meaning in English (2.3kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "insulin",
        "3": "aspartate",
        "alt2": "aspart(ate)"
      },
      "expansion": "insulin + aspart(ate)",
      "name": "af"
    }
  ],
  "etymology_text": "From insulin + aspart(ate).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "insulin aspart (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "coordinate_terms": [
        {
          "sense": "Insulin analogues as pharmaceutical drugs",
          "word": "insulin degludec"
        },
        {
          "sense": "Insulin analogues as pharmaceutical drugs",
          "word": "insulin detemir"
        },
        {
          "sense": "Insulin analogues as pharmaceutical drugs",
          "word": "insulin glargine"
        },
        {
          "sense": "Insulin analogues as pharmaceutical drugs",
          "word": "insulin glulisine"
        },
        {
          "sense": "Insulin analogues as pharmaceutical drugs",
          "word": "insulin lispro"
        }
      ],
      "glosses": [
        "A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others."
      ],
      "hypernyms": [
        {
          "word": "insulin analogue"
        }
      ],
      "id": "en-insulin_aspart-en-noun-PnPtLXUy",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "short-acting",
          "short-acting"
        ],
        [
          "recombinant",
          "recombinant"
        ],
        [
          "insulin",
          "insulin"
        ],
        [
          "insulin analogue",
          "insulin analogue"
        ],
        [
          "subcutaneous",
          "subcutaneous"
        ],
        [
          "injection",
          "injection"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɪn.səl.ɪn ˈæ.spɑɹt/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "insulin aspart"
}
{
  "coordinate_terms": [
    {
      "sense": "Insulin analogues as pharmaceutical drugs",
      "word": "insulin degludec"
    },
    {
      "sense": "Insulin analogues as pharmaceutical drugs",
      "word": "insulin detemir"
    },
    {
      "sense": "Insulin analogues as pharmaceutical drugs",
      "word": "insulin glargine"
    },
    {
      "sense": "Insulin analogues as pharmaceutical drugs",
      "word": "insulin glulisine"
    },
    {
      "sense": "Insulin analogues as pharmaceutical drugs",
      "word": "insulin lispro"
    }
  ],
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "insulin",
        "3": "aspartate",
        "alt2": "aspart(ate)"
      },
      "expansion": "insulin + aspart(ate)",
      "name": "af"
    }
  ],
  "etymology_text": "From insulin + aspart(ate).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "insulin aspart (uncountable)",
      "name": "en-noun"
    }
  ],
  "hypernyms": [
    {
      "word": "insulin analogue"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English compound terms",
        "English entries with incorrect language header",
        "English lemmas",
        "English multiword terms",
        "English nouns",
        "English terms with IPA pronunciation",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "short-acting",
          "short-acting"
        ],
        [
          "recombinant",
          "recombinant"
        ],
        [
          "insulin",
          "insulin"
        ],
        [
          "insulin analogue",
          "insulin analogue"
        ],
        [
          "subcutaneous",
          "subcutaneous"
        ],
        [
          "injection",
          "injection"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɪn.səl.ɪn ˈæ.spɑɹt/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "insulin aspart"
}

This page is a part of the kaikki.org machine-readable English dictionary. This dictionary is based on structured data extracted on 2024-05-18 from the enwiktionary dump dated 2024-05-02 using wiktextract (1d5a7d1 and 304864d). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.